- Molecular Formula: C₇₈H₁₂₅N₂₃O₂₃S₂
- Molecular Weight: 1817.1 g/mol
- Sequence: Tyr-Leu-Arg-Ile-Val-Gin-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
- Molecular Weight: 3367.954 g/mol
- Sequence: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Mal)-NH2
- Molecular Formula: C₃₈H₄₉N₉O₅
- Molecular Weight: 711.86 g/mol
- Sequence: Aib-His-D-2Nal-D-Phe-Lys-NH2
- Targeted Lipolysis & Beta-3 Adrenergic Signaling: Fragment 176-191 isolates the specific region of the hGH molecule responsible for fat restriction and breakdown. Research suggests it selectively targets beta-3 adrenergic receptors (ADRB3) to amplify lipolysis and suppress lipogenesis within adipose tissue cells while driving thermogenesis models in skeletal muscle. Crucially, literature observes that it isolates these traits without inducing unwanted hGH traits like long-bone growth, edema, or altered insulin sensitivity.
- Somatotroph Cell Proliferation: CJC-1295 behaves as a stabilized GHRH analogue that stimulates pituitary somatotroph cells. Preclinical data using GHRH gene deletion (GHRHKO) murine models indicates that frequent introduction preserves standard weight, skeletal dimensions, and lean mass profile without increasing adiposity. Immunohistochemistry reveals that CJC-1295 drives a clear rise in total pituitary RNA and GH mRNA, indicating targeted cellular proliferation.
- Biphasic Neuroendocrine Kinetics: Investigators study this specific combination to evaluate a balanced, biphasic pharmacokinetic model. Ipamorelin, a selective ghrelin mimetic with a brief 2-hour half-life, triggers an immediate, rapid short-term pulse of growth hormone via calcium channel and adrenergic pathways. Conversely, CJC-1295 delivers extended, long-term influence to sustain baseline concentrations and maximize overall physiological availability without receptor desensitization.
- Extracellular Matrix & Skeletal Mineralization: Beyond metabolic pathways, both Ipamorelin and Fragment 176-191 are heavily evaluated for structural repair modeling. Real-time DXA and peripheral quantitative computed tomography (pQCT) scans indicate that Ipamorelin acts directly on osteoblasts to enhance total bone cross-sectional area, tibial dimensions, and vertebral bone mineral content (BMC), making this blend a versatile choice for studying cell-aging mitigation.
- Verified Purity: ≥ 99% purity guaranteed through mass spectrometry and HPLC profiling.
- USA Vetted: Independent laboratory testing ensures absolute structural identity, correct molecular mass, and zero cross-contaminants.
- Research Use Only: This compound is synthesized exclusively for in vitro laboratory experimentation and preclinical evaluation.




Reviews
There are no reviews yet.